medigraphic.com
ISSN 2448-8909 (Print)

2022, Number 7

<< Back Next >>

Med Crit 2022; 36 (7)

Association of body mass index with prolonged invasive mechanical ventilation in patients with infection by SARS-CoV-2 in the Intensive Care Unit

Estrada PJ, Jaramillo SEA, Alva ANV

Language: Spanish
References: 20
Page: 457-462
PDF size: 278.39 Kb.


ABSTRACT

Introduction: SARS-CoV-2 infection is a health problem worldwide. It's highly important to identify new clinical manifestations, mainly the serious form of the disease, because it produces severe acute respiratory syndrome, which is responsible for millions of deaths. Several studies associate the serious form of SARS-CoV-2 with high obesity and immune suppression. Objective: to analyze body mass index (BMI) with prolonged invasive mechanical ventilation (IMV) in patients with SARS-CoV-2 from Intensive Care Unit. Material and methods: retrospective correlational and observational study. Results: a significant association between obesity grade (BMI > 30 kg/m2) and mortality was found in patients diagnosed with SARS-CoV-2 under invasive mechanical ventilation through more than 20 days. Obesity grade I (p = 0.001) and II (p = 0.008) showed higher influence on patient's mortality with induced mechanical ventilation. Conclusions: patients with obesity (BMI > 30 kg/m2), mainly grades I and II showed higher mortality and risk of prolonged invasive mechanical ventilation, so it is important to diagnose and apply early and proper treatment to this type of patients in order to reduce mortality.


REFERENCES

  1. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-1207.

  2. Anderson MR, Geleris J, Anderson DR, Zucker J, Nobel YR, Freedberg D, et al. Body mass index and risk for intubation or death in SARS-CoV-2 infection: a retrospective cohort study. Ann Intern Med. 2020;173(10):782-790.

  3. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782-793.

  4. Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus disease 2019-COVID-19. Clin Microbiol Rev. 2020;33(4):e00028-20.

  5. Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7(1):4.

  6. Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev. 2020;21(11):e13128.

  7. Gong MN, Bajwa EK, Thompson BT, Christiani DC. Body mass index is associated with the development of acute respiratory distress syndrome. Thorax. 2010;65(1):44-50.

  8. Zhao Y, Li Z, Yang T, Wang M, Xi X. Is body mass index associated with outcomes of mechanically ventilated adult patients in intensive critical units? A systematic review and meta-analysis. PLoS One. 2018;13(6):e0198669.

  9. Saad M, Laghi FA Jr, Brofman J, Undevia NS, Shaikh H. Long-term acute care hospital outcomes of mechanically ventilated patients with coronavirus disease 2019. Crit Care Med. 2022;50(2):256-263.

  10. Hernandez-Romieu AC, Adelman MW, Hockstein MA, Robichaux CJ, Edwards JA, Fazio JC, et al. Timing of intubation and mortality among critically ill coronavirus disease 2019 patients: a single-center cohort study. Crit Care Med. 2020;48(11):e1045-e1053.

  11. Kooistra EJ, Brinkman S, van der Voort PHJ, de Keizer NF, Dongelmans DA, Kox M, et al. Body mass index and mortality in coronavirus disease 2019 and other diseases: a cohort study in 35,506 ICU patients. Crit Care Med. 2022;50(1):e1-e10.

  12. Frank RC, Mendez SR, Stevenson EK, Guseh JS, Chung M, Silverman MG. Obesity and the risk of intubation or death in patients with coronavirus disease 2019. Crit Care Med. 2020;48(11):e1097-e1101.

  13. Petrova D, Salamanca-Fernández E, Rodríguez Barranco M, Navarro Pérez P, Jiménez Moleón JJ, Sánchez MJ. La obesidad como factor de riesgo en personas con COVID-19: posibles mecanismos e implicaciones. Aten Primaria. 2020;52(7):496-500.

  14. Gil R, Bitar P, Deza C, Dreyse J, Florenzano MIbarra C, et al. Cuadro clínico del COVID-19. Rev Med Clin Condes. 2021;32(1):20-29.

  15. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;323(18):1824-1836.

  16. Bouadma L, Lescure FX, Lucet JC, Yazdanpanah Y, Timsit JF. Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists. Intensive Care Med. 2020;46(4):579-582.

  17. Gao M, Piernas C, Astbury NM, Hippisley-Cox J, O'Rahilly S, Aveyard P, et al. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study. Lancet Diabetes Endocrinol. 2021;9(6):350-359.

  18. Demeulemeester F, de Punder K, van Heijningen M, van Doesburg F. Obesity as a risk factor for severe COVID-19 and complications: a review. Cells. 2021;10(4):933.

  19. Mohammad S, Aziz R, Al Mahri S, Malik SS, Haji E, Khan AH, et al. Obesity and COVID-19: what makes obese host so vulnerable? Immun Ageing. 2021;18(1):1.

  20. Vera-Zertuche JM, Mancilla-Galindo J, Tlalpa-Prisco M, Aguilar-Alonso P, Aguirre-García MM, Segura-Badilla O, et al. Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study. Epidemiol Infect. 2021;149:e109.




2020     |     www.medigraphic.com